Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer.
Di Fiore
F
F
Charbonnier
F
F
Lefebure
B
B
Laurent
M
M
Le Pessot
F
F
Michel
P
P
Frebourg
T
T
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000097:blood* / Q000188:drug therapy* / Q000473:pathology; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D011905:Genes, ras; D006801:Humans; D009154:Mutation; D009362:Neoplasm Metastasis
D000970:Antineoplastic Agents; D066246:ErbB Receptors